Esperion Therapeutics | Creditori Commerciali

Prezzo Delle Azioni
3.49
Cambio Giornaliero
0.10 2.80%
Mensile
-1.83%
Annuale
85.37%
Q1 Previsione
2.70




Creditori Commerciali Cambiamento Data
AbbVie USD 32.25B 1.2B 2025-06
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amarin USD 36.71M 8M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cipla INR 30.35B 1.98B 2025-09
CSL USD 3.46B 484M 2025-06
Cytokinetics USD 22.08M 46.46M 2025-09
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 4.26B 186.5M 2025-09
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Geron USD 11.11M 2.88M 2025-09
Grifols EUR 1.04B 183.31M 2025-06
Halozyme Therapeutics USD 15.36M 3.33M 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 945K 48K 2025-09
Moderna USD 267M 92M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12


Esperion Therapeutics Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.